Cargando…
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy—a report of long-term follow-up of serial cases and literature review
The aims of this paper are to report hepatitis B virus reactivation in 12 patients with rheumatic disease undergoing immunosuppressive therapy and to evaluate whether pre-emptive antiviral therapy is necessary in patients receiving disease-modifying anti-rheumatic drugs. From January 2008 to March 2...
Autores principales: | Xuan, Dandan, Yu, Yiqi, Shao, Linyun, Wang, Jiali, Zhang, Wenhong, Zou, Hejian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962582/ https://www.ncbi.nlm.nih.gov/pubmed/24343455 http://dx.doi.org/10.1007/s10067-013-2450-9 |
Ejemplares similares
-
COVID-19 with rheumatic diseases: a report of 5 cases
por: Cheng, Chuanfang, et al.
Publicado: (2020) -
Prevention of Hepatitis B reactivation in the setting of immunosuppression
por: Pattullo, Venessa
Publicado: (2016) -
HIV and HCV Cooperatively Promote Hepatic Fibrogenesis via Induction of Reactive Oxygen Species and NFκB
por: Lin, Wenyu, et al.
Publicado: (2011) -
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
por: Pelechas, Eleftherios, et al.
Publicado: (2022) -
Risk factors associated with cytomegalovirus reactivation in patients receiving immunosuppressive therapy for rheumatic diseases: a retrospective study
por: Shimada, Tatsuya, et al.
Publicado: (2022)